What is Adaptive Biotechnologies Inventory-to-Revenue?
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. Adaptive Biotechnologies's Average Total Inventories for the quarter that ended in Dec. 2023 was $17.0 Mil. Adaptive Biotechnologies's Revenue for the
three
months ended in Dec. 2023 was $45.8 Mil.
Adaptive Biotechnologies's Inventory-to-Revenue for the quarter that ended in Dec. 2023 was 0.37.
Adaptive Biotechnologies's Inventory-to-Revenue for the quarter that ended in Dec. 2023
declined
from Sep. 2023 (0.51) to Sep. 2023 (0.37)
A decrease in the Inventory-to-Revenue from one quarter to next indicates that one of these is occurring:
1. investment in inventory is shrinking in relation to revenue
2. revenue are increasing
No matter which situation is causing the reduction in the Inventory-to-Revenue, either one suggests that business's inventory levels and its cash flow are effectively managed.
Days Inventory indicates the number of days of goods in sales that a company has in the inventory.
Adaptive Biotechnologies's Days Inventory for the
three
months ended in Dec. 2023 was 78.94.
Inventory Turnover measures how fast the company turns over its inventory within a year.
Adaptive Biotechnologies's Inventory Turnover for the quarter that ended in Dec. 2023 was 1.16.
Adaptive Biotechnologies Inventory-to-Revenue Historical Data
The historical data trend for Adaptive Biotechnologies's Inventory-to-Revenue can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Adaptive Biotechnologies's Inventory-to-Revenue
For the Biotechnology subindustry, Adaptive Biotechnologies's Inventory-to-Revenue, along with its competitors' market caps and Inventory-to-Revenue data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Adaptive Biotechnologies's Inventory-to-Revenue Distribution in the Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Adaptive Biotechnologies's Inventory-to-Revenue distribution charts can be found below:
* The bar in red indicates where Adaptive Biotechnologies's Inventory-to-Revenue falls into.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Adaptive Biotechnologies's Inventory-to-Revenue for the fiscal year that ended in Dec. 2023 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
An increase in Inventory-to-Revenue from one quarter to the next indicates that one of the following is happening:
1. investment in inventory is growing more rapidly than revenue
2. revenue are dropping
No matter which situation is causing the problem, an increase in the Inventory-to-Revenue may signal an oncoming cash flow problem.
Likewise, a decrease in the Inventory-to-Revenue from one quarter to next indicates that one of these is occurring:
1. investment in inventory is shrinking in relation to revenue
2. revenue are increasing
No matter which situation is causing the reduction in the Inventory-to-Revenue, either one suggests that business's inventory levels and its cash flow are effectively managed.
More Related Terms:
1. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.
Adaptive Biotechnologies's Days Inventory for the
three
months ended in Dec. 2023 is calculated as:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Adaptive Biotechnologies Inventory-to-Revenue Related Terms
Thank you for viewing the detailed overview of Adaptive Biotechnologies's Inventory-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.
Adaptive Biotechnologies (Adaptive Biotechnologies) Business Description
Adaptive Biotechnologies Corp is a company advancing the field of immune-driven medicine by harnessing the inherent biology of the adaptive immune system to transform the diagnosis and treatment of disease. Its clinical diagnostic product, clonoSEQ, is test authorized by the FDA for the detection and monitoring of minimal residual disease ("MRD") in patients with multiple myeloma ("MM"), B cell acute lymphoblastic leukemia ("ALL") and chronic lymphocytic leukemia ("CLL") and is also available as a CLIA-validated laboratory developed test ("LDT") for patients with other lymphoid cancers, including diffuse large B-cell lymphoma ("DLBCL").
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
ADPT has been successfully added to your 